In a recent study, Guo et al. demonstrated that the SOX7 gene was downregulated in 47% of the pancreatic adenocarcinomas, and tumor-specific inactivation of SOX7 by promoter hypermethylation was found in 48% of the primary pancreatic tumors tested [20]. The gene discussed is SOX7; the disease is neoplasm.